Global burden of CVD: Focus on secondary prevention of cardiovascular disease

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages S1-S7

  Bansilal, Sameer ^a,b   Castellano, José M ^a,b,c   Fuster, Valentín ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c Grupo HM Hospitales   (Spain)

Author keywords

Accessibility to drugs; Global cardiovascular disease; Secondary prevention; Therapeutic adherence

Indexed keywords

CARDIOVASCULAR AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSAL ATTRIBUTION; HEALTH CARE ACCESS; HUMAN; MEDICATION COMPLIANCE; PANDEMIC; PATIENT INFORMATION; PREVALENCE; PRIORITY JOURNAL; SECONDARY PREVENTION; SOCIAL STATUS; TREATMENT PLANNING; TREATMENT REFUSAL; CARDIOVASCULAR DISEASES; COST OF ILLNESS; ECONOMICS; HEALTH; HEALTH CARE DELIVERY; INCIDENCE; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; COST OF ILLNESS; GLOBAL HEALTH; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; MEDICATION ADHERENCE; RISK FACTORS; SECONDARY PREVENTION;

EID: 84964902506     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/S0167-5273(15)31026-3     Document Type: Article

References (60)

1. C Writing, SC Smith Jr., A Collins, R Ferrari, DR Holmes Jr., S Logstrup, DV McGhie, J Ralston, RL Sacco, H Stam, K Taubert, DA Wood, WA Zoghbi Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke) Glob Heart 7 2012 297 305
2. Organization WH and UNAIDS Prevention of cardiovascular disease 2007 World Health Organization
3. WHO. WHO. Data and statistics.
4. M Nichols, N Townsend, P Scarborough, M Rayner Cardiovascular disease in Europe: epidemiological update Eur Heart J 34 2013 3028 3034
5. SC Chung, R Gedeborg, O Nicholas, S James, A Jeppsson, C Wolfe, P Heuschmann, L Wallentin, J Deanfield, A Timmis, T Jernberg, H Hemingway Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK Lancet 383 2014 1305 1312
6. D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, S de Ferranti, JP Despres, HJ Fullerton, VJ Howard, MD Huffman, SE Judd, BM Kissela, DT Lackland, JH Lichtman, LD Lisabeth, S Liu, RH Mackey, DB Matchar, DK McGuire, ER Mohler 3rd, CS Moy, P Muntner, ME Mussolino, K Nasir, RW Neumar, G Nichol, L Palaniappan, DK Pandey, MJ Reeves, CJ Rodriguez, PD Sorlie, J Stein, A Towfighi, TN Turan, SS Virani, JZ Willey, D Woo, RW Yeh, MB Turner American Heart Association Statistics C and Stroke Statistics S. Heart disease and stroke statistics-2015 update: a report from the American Heart Association Circulation 131 2015 e29 322
7. P Tuppin, A Neumann, N Danchin, A Weill, P Ricordeau, C de Peretti, H Allemand Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database Arch Cardiovasc Dis 102 2009 279 292
8. E Andres, A Cordero, P Magan, E Alegria, M Leon, E Luengo, RM Botaya, L Garcia Ortiz, JA Casasnovas Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study Rev Esp Cardiol (Engl Ed) 65 2012 414 420
9. B Bischoff, S Silber, BM Richartz, L Pieper, J Klotsche, DHU Wittchen, Study-Group Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany Clin Res Cardiol 95 2006 405 412
10. Stranges E, Barrett M, Wier LM and Andrews RM. Readmissions for heart attack, 2009. 2012.
11. MB Koch, M Davidsen, LV Andersen, K Juel, GB Jensen Increasing prevalence despite decreasing incidence of ischaemic heart disease and myocardial infarction. A national register based perspective in Denmark, 1980-2009 Eur J Prev Cardiol 22 2015 189 195
12. K Smolina, FL Wright, M Rayner, MJ Goldacre Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study Eur J Public Health 22 2012 848 853
13. K Smolina, FL Wright, M Rayner, MJ Goldacre Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010 Circ Cardiovasc Qual Outcomes 5 2012 532 540
14. A Alwan Global status report on noncommunicable diseases 2010 2011 World Health Organization
15. M Law, J Morris, N Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies Bmj 2009 338
16. C Antithrombotic Trialists, C Baigent, L Blackwell, R Collins, J Emberson, J Godwin, R Peto, J Buring, C Hennekens, P Kearney, T Meade, C Patrono, MC Roncaglioni, A Zanchetti Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
17. C Cholesterol Treatment Trialists, C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, EH Barnes, A Keech, J Simes, R Collins Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
18. I Graham, D Atar, K Borch-Johnsen, G Boysen, G Burell, R Cifkova, J Dallongeville, G De Backer, S Ebrahim, B Gjelsvik, C Herrmann-Lingen, A Hoes, S Humphries, M Knapton, J Perk, SG Priori, K Pyorala, Z Reiner, L Ruilope, S Sans-Menendez, WS Op Reimer, P Weissberg, D Wood, J Yarnell, JL Zamorano, E Walma, T Fitzgerald, MT Cooney, A Dudina, A Vahanian, J Camm, R De Caterina, V Dean, K Dickstein, C Funck-Brentano, G Filippatos, I Hellemans, SD Kristensen, K McGregor, U Sechtem, S Silber, M Tendera, P Widimsky, JL Zamorano, A Altiner, E Bonora, PN Durrington, R Fagard, S Giampaoli, H Hemingway, J Hakansson, SE Kjeldsen, ML Larsen, G Mancia, AJ Manolis, K Orth-Gomer, T Pedersen, M Rayner, L Ryden, M Sammut, N Schneiderman, AF Stalenhoef, L Tokgozoglu, O Wiklund, A Zampelas European Society of C, European Association for Cardiovascular P, Rehabilitation, Council on Cardiovascular N, European Association for Study of D, International Diabetes Federation E, European Stroke I, Society of Behavioural M, European Society of H, Europe W, European Heart N and European Atherosclerosis S. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 Suppl 2 2007 S1 113
19. J Perk, G De Backer, H Gohlke, I Graham, Ž Reiner, M Verschuren, C Albus, P Benlian, G Boysen, R Cifkova European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) European heart journal 33 2012 1635 1701
20. N Stone, J Robinson, A Lichtenstein, D Goff Jr, D Lloyd-Jones, S Smith Jr, C Blum, J Schwartz ACC/AHA Cholesterol Guideline Panel. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline Ann Intern Med 160 2014 339 343
21. SC Smith Jr., EJ Benjamin, RO Bonow, LT Braun, MA Creager, BA Franklin, RJ Gibbons, SM Grundy, LF Hiratzka, DW Jones, DM Lloyd-Jones, M Minissian, L Mosca, ED Peterson, RL Sacco, J Spertus, JH Stein, KA Taubert World Heart F and the Preventive Cardiovascular Nurses A. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 2011 2458 2473
22. K Kotseva, D Wood, G De Backer, D De Bacquer, K Pyorala, U Keil, ES Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet 373 2009 929 940
23. S Yusuf, S Islam, CK Chow, S Rangarajan, G Dagenais, R Diaz, R Gupta, R Kelishadi, R Iqbal, A Avezum, A Kruger, R Kutty, F Lanas, L Lisheng, L Wei, P Lopez-Jaramillo, A Oguz, O Rahman, H Swidan, K Yusoff, W Zatonski, A Rosengren, KK Teo, I Prospective Urban Rural Epidemiology Study Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey Lancet 378 2011 1231 1243
24. U Zeymer, G Berkenboom, Z Coufal, M Belger, M Sartral, K Norrbacka, A Bakhai, A investigators Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR) Int J Cardiol 170 2013 239 245
25. M Lafeber, DE Grobbee, W Spiering, Y van der Graaf, ML Bots, FL Visseren, SS Group The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus Eur J Prev Cardiol 20 2013 771 778
26. P Muntner, D Mann, RP Wildman, D Shimbo, V Fuster, M Woodward Projected impact of polypill use among US adults: medication use, cardiovascular risk reduction, and side effects American heart journal 161 2011 719 725
27. S Mendis, D Abegunde, S Yusuf, S Ebrahim, G Shaper, H Ghannem, B Shengelia WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHOPREMISE) Bull World Health Organ 83 2005 820 829
28. Accessibility PD. Issues in International Health Policy. 2010.
29. RB Haynes, KA McKibbon, R Kanani Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications Lancet 348 1996 383 386
30. M O'Flaherty, I Buchan, S Capewell Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? Heart 99 2013 159 162
31. SH Naderi, JP Bestwick, DS Wald Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients Am J Med 125 2012 882 7e1
32. R Chowdhury, H Khan, E Heydon, A Shroufi, S Fahimi, C Moore, B Stricker, S Mendis, A Hofman, J Mant, OH Franco Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences Eur Heart J 34 2013 2940 2948
33. E Sabaté Adherence to long-term therapies: evidence for action 2003 World Health Organization
34. JM Castellano, G Sanz, A Fernandez Ortiz, E Garrido, S Bansilal, V Fuster A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality J Am Coll Cardiol 64 2014 613 621
35. S Perreault, L Blais, D Lamarre, A Dragomir, D Berbiche, L Lalonde, C Laurier, F St-Maurice, J Collin Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention Br J Clin Pharmacol 59 2005 564 573
36. Y Kassab, Y Hassan, N Abd Aziz, O Ismail, H AbdulRazzaq Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes Int J Clin Pharm 35 2013 275 280
37. JM Castellano, G Sanz, JL Penalvo, S Bansilal, A Fernandez-Ortiz, L Alvarez, L Guzman, JC Linares, F Garcia, F D'Aniello, JA Arnaiz, S Varea, F Martinez, A Lorenzatti, I Imaz, LM Sanchez-Gomez, MC Roncaglioni, M Baviera, SC Smith Jr., K Taubert, S Pocock, CME Brotons, V Fuster A polypill strategy to improve adherence: results from the FOCUS project J Am Coll Cardiol 64 2014 2071 2082
38. L Osterberg, T Blaschke Adherence to medication N Engl J Med 353 2005 487 497
39. NK Choudhry, S Setoguchi, R Levin, WC Winkelmayer, WH Shrank Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients Pharmacoepidem Dr S 17 2008 1189 1196
40. A Akincigil, JR Bowblis, C Levin, S Jan, M Patel, S Crystal Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction J Gen Intern Med 23 2008 115 121
41. TA Ens, CC Seneviratne, C Jones, TL Green, KM King-Shier South Asians' cardiac medication adherence Eur J Cardiovasc Nurs 13 2014 357 368
42. PM Ho, DJ Magid, SM Shetterly, KL Olson, TM Maddox, PN Peterson, FA Masoudi, JS Rumsfeld Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease American heart journal 155 2008 772 779
43. GR Dagenais, J Pogue, K Fox, ML Simoons, S Yusuf Angiotensin-convertingenzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials The Lancet 368 2006 581 588
44. D Mukherjee, J Fang, S Chetcuti, M Moscucci, E Kline-Rogers, KA Eagle Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation 109 2004 745 749
45. LK Newby, NM LaPointe, AY Chen, JM Kramer, BG Hammill, ER DeLong, LH Muhlbaier, RM Califf Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
46. MJ Taylor, PA Scuffham, PL McCollam, DE Newby Acute coronary syndromes in Europe: 1-year costs and outcomes Current Medical Research and Opinion® 23 2007 495 503
47. A Bitton, NK Choudhry, OS Matlin, K Swanton, WH Shrank The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review Am J Med 126 2013 357 e7-357 e27.
48. E Heeley, CS Anderson, Y Huang, S Jan, Y Li, M Liu, J Sun, E Xu, Y Wu, Q Yang, J Zhang, S Zhang, J Wang, QI China Role of health insurance in averting economic hardship in families after acute stroke in China Stroke 40 2009 2149 2156
49. ZA Marcum, MA Sevick, SM Handler Medication nonadherence: a diag-nosable and treatable medical condition JAMA 309 2013 2105 2106
50. AD Mwaka, HR Wabinga, H Mayanja-Kizza Mind the gaps: a qualitative study of perceptions of healthcare professionals on challenges and proposed remedies for cervical cancer help-seeking in post conflict northern Uganda BMC family practice 14 2013 193
51. NK Choudhry, AA Krumme, PM Ercole, C Girdish, DL Isaman, OS Matlin, TA Brennan, WH Shrank, JM Franklin Rationale and design of the Randomized Evaluation to Measure Improvements in Non-adherence from Low-Cost Devices (REMIND) trial Contemporary clinical trials 43 2015 53 59
52. JM Castellano, G Sanz, V Fuster Evolution of the polypill concept and ongoing clinical trials Canadian Journal of Cardiology 30 2014 520 526
53. JM Castellano, G Sanz, JL Peñalvo, S Bansilal, A Fernández-Ortiz, L Alvarez, L Guzmán, JC Linares, F García, F D'Aniello A polypill strategy to improve adherence: results from the FOCUS project Journal of the American College of Cardiology 64 2014 2071 2082
54. L Berben, L Bogert, ME Leventhal, B Fridlund, T Jaarsma, TM Norekvål, K Smith, A Strömberg, DR Thompson, S De Geest Which interventions are used by health care professionals to enhance medication adherence in cardiovascular patients? A survey of current clinical practice European Journal of Cardiovascular Nursing 10 2011 14 21
55. PT Nieuwkerk, MC Nierman, MN Vissers, M Locadia, P Greggers-Peusch, LP Knape, JJ Kastelein, MA Sprangers, HC de Haes, ES Stroes Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk The American journal of cardiology 110 2012 666 672
56. C Hohmann, T Neumann-Haefelin, JM Klotz, A Freidank, R Radziwill Adherence to hospital discharge medication in patients with ischemic stroke A prospective, interventional 2phase study Stroke 44 2013 522 524
57. SC Kalichman, T Grebler Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS Psychosomatic medicine 72 2010 810
58. S Parashar, AK Palmer, N O'Brien, K Chan, A Shen, S Coulter, JS Montaner, RS Hogg Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed AIDS and Behavior 15 2011 1612 1622
59. R Nieuwlaat, N Wilczynski, T Navarro, N Hobson, R Jeffery, A Keepanasseril, T Agoritsas, N Mistry, A Iorio, S Jack Interventions for enhancing medication adherence Cochrane Database Syst Rev 2014 11
60. Eurostat. Database -Eurostat.